NIOS exam date sheet 2025: The National Institute of Open Schooling (NIOS) has released the official date sheet for the 2025 Public Examination (Theory) for Class 10 and 12. The exams will be ...

NIOS Class 10, 12 date sheets: National Institute of Open Schooling (NIOS) has published the detailed calendar for the 2025 Class 10 (senior secondary) and Class 12 (secondary) public exams. As per ...

BSEB Merit Scholarship 2025: The Bihar government has launched the Medhasoft portal for students who passed the BSEB Class 10 or 12 exam in 2025 with a first or second division to apply for financial ...

Neutra, a naturalized American citizen who emigrated from Austria, was instrumental in creating Southern California’s midcentury-modern design aesthetic, while the Case Study Houses, a program ...

During the last three months, 10 analysts shared their evaluations of Antero Resources (NYSE:AR), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the table ...

A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the ...

A new study finds that heterosexual men exposed to sexy pirates may rate their real-life romantic partners less favorably afterward. Meanwhile, men and women exposed to the Hollywood blockbuster ...

A SpaceX Falcon 9 rocket launched the Space Development Agency's first Tranche 1 satellites on Sept. 10, 2025 from Vandenberg Space Force Base, California. (SpaceX) The Space Development Agency ...

HAWLEY, Minn. — About five years ago, during the height of the pandemic, developer Austin Peterson purchased about two acres of land next to Highway 10 in Hawley. The fact that thousands of people ...

The McKinney Community Development Corporation announced project grants totaling $10.6 million that help support quality-of-life projects in the city. The MCDC evaluates funding proposals through a ...

Data from the late-stage MAPLE-HCM study position Cytokinetics’ cardiac myosin inhibitor aficamten as a potential first-line therapy for patients with obstructive hypertrophic cardiomyopathy.